RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.

Saved in:
Bibliographic Details
Title: RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.
Authors: Krivokuca A; Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia., Yanowski K; Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Rakobradovic J; Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia., Benitez J; Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Brankovic-Magic M; Department of Experimental Oncology, Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
Source: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2015; Vol. 15 (6), pp. 775-81.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101256509 Publication Model: Print Cited Medium: Internet ISSN: 1875-8592 (Electronic) Linking ISSN: 15740153 NLM ISO Abbreviation: Cancer Biomark Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first